Archangels - Making The Future

News

Touch Bionics unveils new products at AOPA

Prosthetics technology company continues to innovate.Las Vegas, NV - September 20, 2011 - Touch Bionics®, the upper limb prosthetic technology provider, today revealed new and upgraded products at the American Orthotic & Prosthetic Association National Assembly in Las Vegas.

Key developments include the i-limbTM ultra, an upgraded version of its flagship prosthetic hand solution, and virtu-limbTM, a prosthetic training and simulation tool. Also introduced at AOPA, living image is an imaging system that accurately captures the color and appearance of limbs for the creation of the livingskin® range of passive silicone prostheses.

 "We are pleased to introduce i-limb ultra, virtu-limb and living image at AOPA," said Ian Stevens, CEO, Touch Bionics. "We believe that prosthetists and therapists will find these products to be very beneficial to their patients. New technology needs to be properly supported and Touch Bionics is fully committed to providing clinicians with comprehensive training, as well as clinical, technical and patient outcome support."

About Touch Bionics
Touch Bionics is a provider of world-leading prosthetic technologies and supporting services designed to achieve positive outcomes for people with upper limb deficiencies. Our products include myoelectric prosthetic hand and prosthetic finger solutions, as well as passive silicone prostheses that closely match the natural appearance of the wearer. We are committed to helping ensure that our patients and customers have the best possible experience with our products by supporting them with training and a full range of clinical services.

Note to editors: Visit the download section of our web site to access images relating to these new products.

Media contacts:

Danny Sullivan, Communications Manager

Tel: +44 (0) 1506 445 411
Mobile: +44 (0) 7894 393 961
Email: danny.sullivan@touchbionics.com
Twitter: @touchbionics

Linda Forrest
inmedia Public Relations
Phone: +1 613-983-3300
Email: lforrest@inmedia.com
Twitter: @lindaforrest

 


Back to list

Latest News

Cable gets to grips with Great British design

25 Jun 2014
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.

MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer

23 Jun 2014
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.

Touch Bionics founder receives Queen’s Honour

16 Jun 2014
David Gow named Commander of the Order of the British Empire Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.

Touch Bionics introduces new control method for bionic hand

14 May 2014
Livingston, Scotland – May 14, 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, has announced the introduction of the latest enhancements to the i-limb™ ultra revolution at the OTWorld 2014 International Congress taking place in Leipzig, Germany.

Technology Strategy Board Biomedical Catalyst Award to Drive Development of Novel System to Assess and Manage Tooth Decay (Dental Caries)

09 May 2014
Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has received a prestigious Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors Archangel Informal Investment and the Scottish Investment Bank, the investment arm of Scottish Enterprise.